240 related articles for article (PubMed ID: 34485611)
21. Ocular Inflammatory Response to Intravitreal Injection of Adeno-Associated Virus Vector: Relative Contribution of Genome and Capsid.
Timmers AM; Newmark JA; Turunen HT; Farivar T; Liu J; Song C; Ye GJ; Pennock S; Gaskin C; Knop DR; Shearman MS
Hum Gene Ther; 2020 Jan; 31(1-2):80-89. PubMed ID: 31544533
[TBL] [Abstract][Full Text] [Related]
22. Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors.
Hösel M; Huber A; Bohlen S; Lucifora J; Ronzitti G; Puzzo F; Boisgerault F; Hacker UT; Kwanten WJ; Klöting N; Blüher M; Gluschko A; Schramm M; Utermöhlen O; Bloch W; Mingozzi F; Krut O; Büning H
Hepatology; 2017 Jul; 66(1):252-265. PubMed ID: 28318036
[TBL] [Abstract][Full Text] [Related]
23. Application of polyploid adeno-associated virus vectors for transduction enhancement and neutralizing antibody evasion.
Chai Z; Sun J; Rigsbee KM; Wang M; Samulski RJ; Li C
J Control Release; 2017 Sep; 262():348-356. PubMed ID: 28789965
[TBL] [Abstract][Full Text] [Related]
24. Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates.
Unzu C; Hervás-Stubbs S; Sampedro A; Mauleón I; Mancheño U; Alfaro C; de Salamanca RE; Benito A; Beattie SG; Petry H; Prieto J; Melero I; Fontanellas A
J Transl Med; 2012 Jun; 10():122. PubMed ID: 22704060
[TBL] [Abstract][Full Text] [Related]
25. Intramuscular administration of AAV overcomes pre-existing neutralizing antibodies in rhesus macaques.
Greig JA; Calcedo R; Grant RL; Peng H; Medina-Jaszek CA; Ahonkhai O; Qin Q; Roy S; Tretiakova AP; Wilson JM
Vaccine; 2016 Dec; 34(50):6323-6329. PubMed ID: 27817961
[TBL] [Abstract][Full Text] [Related]
26. Repeat Dosing of AAV2.5T to Ferret Lungs Elicits an Antibody Response That Diminishes Transduction in an Age-Dependent Manner.
Tang Y; Yan Z; Lin S; Huntemann ED; Feng Z; Park SY; Sun X; Yuen E; Engelhardt JF
Mol Ther Methods Clin Dev; 2020 Dec; 19():186-200. PubMed ID: 33209961
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic T lymphocyte responses to transgene product, not adeno-associated viral capsid protein, limit transgene expression in mice.
Siders WM; Shields J; Kaplan J; Lukason M; Woodworth L; Wadsworth S; Scaria A
Hum Gene Ther; 2009 Jan; 20(1):11-20. PubMed ID: 18828728
[TBL] [Abstract][Full Text] [Related]
28. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.
Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW
Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574
[TBL] [Abstract][Full Text] [Related]
29. Pre-clinical efficacy and dosing of an AAV8 vector expressing human methylmalonyl-CoA mutase in a murine model of methylmalonic acidemia (MMA).
Chandler RJ; Venditti CP
Mol Genet Metab; 2012 Nov; 107(3):617-9. PubMed ID: 23046887
[TBL] [Abstract][Full Text] [Related]
30. Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B.
George LA; Ragni MV; Rasko JEJ; Raffini LJ; Samelson-Jones BJ; Ozelo M; Hazbon M; Runowski AR; Wellman JA; Wachtel K; Chen Y; Anguela XM; Kuranda K; Mingozzi F; High KA
Mol Ther; 2020 Sep; 28(9):2073-2082. PubMed ID: 32559433
[TBL] [Abstract][Full Text] [Related]
31. Factors influencing the development of an anti-factor IX (FIX) immune response following administration of adeno-associated virus-FIX.
Ge Y; Powell S; Van Roey M; McArthur JG
Blood; 2001 Jun; 97(12):3733-7. PubMed ID: 11389010
[TBL] [Abstract][Full Text] [Related]
32. Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscle.
Chandler RJ; Sloan J; Fu H; Tsai M; Stabler S; Allen R; Kaestner KH; Kazazian HH; Venditti CP
BMC Med Genet; 2007 Oct; 8():64. PubMed ID: 17937813
[TBL] [Abstract][Full Text] [Related]
33. Complement is an essential component of the immune response to adeno-associated virus vectors.
Zaiss AK; Cotter MJ; White LR; Clark SA; Wong NC; Holers VM; Bartlett JS; Muruve DA
J Virol; 2008 Mar; 82(6):2727-40. PubMed ID: 18199646
[TBL] [Abstract][Full Text] [Related]
34. Viral serotype and the transgene sequence influence overlapping adeno-associated viral (AAV) vector-mediated gene transfer in skeletal muscle.
Ghosh A; Yue Y; Duan D
J Gene Med; 2006 Mar; 8(3):298-305. PubMed ID: 16385549
[TBL] [Abstract][Full Text] [Related]
35. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
[TBL] [Abstract][Full Text] [Related]
36. Prednisolone and rapamycin reduce the plasma cell gene signature and may improve AAV gene therapy in cynomolgus macaques.
Kistner A; Chichester JA; Wang L; Calcedo R; Greig JA; Cardwell LN; Wright MC; Couthouis J; Sethi S; McIntosh BE; McKeever K; Wadsworth S; Wilson JM; Kakkis E; Sullivan BA
Gene Ther; 2024 Mar; 31(3-4):128-143. PubMed ID: 37833563
[TBL] [Abstract][Full Text] [Related]
37. Liver-directed recombinant adeno-associated viral gene delivery rescues a lethal mouse model of methylmalonic acidemia and provides long-term phenotypic correction.
Carrillo-Carrasco N; Chandler RJ; Chandrasekaran S; Venditti CP
Hum Gene Ther; 2010 Sep; 21(9):1147-54. PubMed ID: 20486773
[TBL] [Abstract][Full Text] [Related]
38. A limited number of transducible hepatocytes restricts a wide-range linear vector dose response in recombinant adeno-associated virus-mediated liver transduction.
Nakai H; Thomas CE; Storm TA; Fuess S; Powell S; Wright JF; Kay MA
J Virol; 2002 Nov; 76(22):11343-9. PubMed ID: 12388694
[TBL] [Abstract][Full Text] [Related]
39. Inverted terminal repeat sequences are important for intermolecular recombination and circularization of adeno-associated virus genomes.
Yan Z; Zak R; Zhang Y; Engelhardt JF
J Virol; 2005 Jan; 79(1):364-79. PubMed ID: 15596830
[TBL] [Abstract][Full Text] [Related]
40. Capsid-specific removal of circulating antibodies to adeno-associated virus vectors.
Bertin B; Veron P; Leborgne C; Deschamps JY; Moullec S; Fromes Y; Collaud F; Boutin S; Latournerie V; van Wittenberghe L; Delache B; Le Grand R; Dereuddre-Bosquet N; Benveniste O; Moullier P; Masurier C; Merten O; Mingozzi F
Sci Rep; 2020 Jan; 10(1):864. PubMed ID: 31965041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
